John-Anthony Robinson

Title: Innovations of John-Anthony Robinson

Introduction

John-Anthony Robinson is a notable inventor based in Wermatswil, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of peptidomimetics. With a total of seven patents to his name, Robinson's work has the potential to impact cancer treatment significantly.

Latest Patents

Robinson's latest patents include the template-fixed β-hairpin peptidomimetics, specifically Cyclo(-Tyr-His-X-Cys-Ser-Ala-Pro-Dab-Arg-Tyr-Cys-Tyr-Gln-Lys-Pro-Pro). This innovation features a disulfide bond between Cys4 and Cys11, along with pharmaceutically acceptable salts. The peptidomimetics exhibit CXCR4 antagonizing properties, which can be utilized in scenarios where cancer is mediated or resulting from CXCR4 receptor activity.

Career Highlights

Throughout his career, Robinson has worked with prominent organizations such as Polyphor Ltd. and Universität Zürich. His experience in these institutions has allowed him to refine his expertise in drug development and innovation.

Collaborations

Robinson has collaborated with notable colleagues, including Daniel Obrecht and Frank Gombert. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

John-Anthony Robinson's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in cancer treatment and drug development.